DrugPatentWatch Database Preview
Hikma Farmaceutica Company Profile
» See Plans and Pricing
What is the competitive landscape for HIKMA FARMACEUTICA, and what generic and branded alternatives to HIKMA FARMACEUTICA drugs are available?
HIKMA FARMACEUTICA has forty approved drugs.
Summary for Hikma Farmaceutica
| US Patents: | 0 |
| Tradenames: | 36 |
| Ingredients: | 30 |
| NDAs: | 40 |
Drugs and US Patents for Hikma Farmaceutica
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma Farmaceutica | TERBUTALINE SULFATE | terbutaline sulfate | INJECTABLE;INJECTION | 078630-001 | May 20, 2009 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Hikma Farmaceutica | CEFUROXIME SODIUM | cefuroxime sodium | INJECTABLE;INJECTION | 065046-001 | Jan 9, 2004 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Hikma Farmaceutica | LEVETIRACETAM | levetiracetam | INJECTABLE;INTRAVENOUS | 090981-001 | Oct 13, 2011 | AP | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
